On February 11th, we invited Professor Dohun Kwon, who is researching TRPV1 structural analysis, to conduct a related seminar at our headquarters.
Despite his busy schedule having just arrived from the United States, the seminar provided an opportunity to discuss the latest research trends on TRPV1 and explore directions for collaboration on TRPV1 structural analysis research.
With many US companies and researchers recently reaching a consensus that TRPV1 is the ultimate target for non-narcotic analgesics, it was a valuable time to discuss the challenges and possibilities encountered in researching many small molecules.
Based on this meeting, both parties agreed to proceed with close collaboration on future research.
We would like to once again thank Professor Kwon for visiting RudaCure and look forward to meaningful research outcomes in the future.
